Cogent’s mastocytosis drug hits ‘home run’ in registrational mid-stage trial

Ayisha Sharma

News Reporter

Cogent Biosciences said it’s working on an FDA submission for its systemic mastocytosis (SM) drug after breezing through a Phase 2 trial in an indolent …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Cogent’s mastocytosis drug hits ‘home run’ in registrational mid-stage trial

Ayisha Sharma

News Reporter

Sign up to read this article for free.

Apogee reports Phase 2 win for eczema drug that could challenge Dupixent and Ebglyss

Compromised drug lot impacts Jasper's chronic hives study, stock falls

Despite delay, KalVista wins FDA approval after Makary's short-lived attempt to intervene

Trump's tax cut law expands orphan drug exclusions, could upend 340B program

Clinician groups sue RFK Jr. and HHS over Covid-19 vaccine recommendation changes

Uncovering the Potential of Targeting the CD38 Pathway for Immune-Mediated Diseases

Co­gent’s mas­to­cy­to­sis drug hits ‘home run’ in reg­is­tra­tional mid-stage tri­al

Ayisha Sharma

News Reporter

Sign up to read this article for free.

Apogee re­ports Phase 2 win for eczema drug that could chal­lenge Dupix­ent and Ebglyss

Com­pro­mised drug lot im­pacts Jasper's chron­ic hives study, stock falls

De­spite de­lay, KalVista wins FDA ap­proval af­ter Makary's short-lived at­tempt to in­ter­vene

Trump's tax cut law ex­pands or­phan drug ex­clu­sions, could up­end 340B pro­gram

Clin­i­cian groups sue RFK Jr. and HHS over Covid-19 vac­cine rec­om­men­da­tion changes

Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases

Cogent’s mastocytosis drug hits ‘home run’ in registrational mid-stage trial

Apogee reports Phase 2 win for eczema drug that could challenge Dupixent and Ebglyss

Compromised drug lot impacts Jasper's chronic hives study, stock falls

Despite delay, KalVista wins FDA approval after Makary's short-lived attempt to intervene

Trump's tax cut law expands orphan drug exclusions, could upend 340B program

Clinician groups sue RFK Jr. and HHS over Covid-19 vaccine recommendation changes

Uncovering the Potential of Targeting the CD38 Pathway for Immune-Mediated Diseases